Hemispherx Biopharma Inc

  • Hemispherx to test drugs against Ebola Monday, 8 Sep 2014 | 8:56 AM ET

    Sept 8- Hemispherx Biopharma Inc said it was evaluating two of its drugs against the deadly Ebola virus in collaboration with a unit of the U.S. Department of Defense. The company said it would test Alferon, which is approved for use in the United States to treat genital warts caused by human papilloma virus.

  • TheStreet.com details the 10 best-performing biopharmaceutical stocks of 2012 and their outlook for 2013.

  • Biotechs Gain on Flu Vaccine Hopes Monday, 5 Oct 2009 | 12:06 PM ET

    The CDC announced today that healthcare workers in Tennessee and Indiana would be amongst the first to get swine flu vaccinations.  The outbreak of the H1N1 swine flu virus has sadly killed over 3,900 peope per a report by the World Health Organization (WHO) on September 25th.  At the same time the race to battle the pandemic has propped up the shares of biotech companies that promise solutions.